RJA
GEVO icon

Ross\Johnson & Associates’s Gevo GEVO Stock Holding History

Ross\Johnson & Associates’s Portfolio GEVO Stock Details GEVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-250
Closed -$290 – 268
2025
Q1 		$290 Buy
+250
New +$419 0.01% 291

Other funds holding GEVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Ross\Johnson & Associates's GEVO Position: Q2 2025 in Review

Ross\Johnson & Associates sold out of Gevo (GEVO) in Q2 2025, closing a stake of 250 shares — an estimated $290 sold.

Ross\Johnson & Associates first reported a position in GEVO in Q1 2025 and held it in 1 quarter. The position peaked at $290 in Q1 2025. 121 funds tracked by Wall St. Rank hold GEVO as of Q2 2025.

  • Ross\Johnson & Associates reported no remaining Gevo position as of Q2 2025 after selling out during the quarter.
  • Ross\Johnson & Associates sold 250 Gevo shares in Q2 2025, an estimated $290.
  • Ross\Johnson & Associates first reported a position in Gevo in Q1 2025 and held it in 1 quarter.
  • Ross\Johnson & Associates's Gevo position peaked at $290 in Q1 2025.
  • 121 funds tracked by Wall St. Rank held Gevo as of Q2 2025.

Based on Ross\Johnson & Associates's 13F filing for Q2 2025, filed 15 Aug 2025.